Selena Daniels, PharmD, PhD, MS

Dr. Selena Daniels serves as a Team Leader in the Division of Clinical Outcome Assessment at the Food and Drug Administration (FDA). She leads a team of expert analysts who provide consultation and advice on clinical outcome assessment (COA) endpoint development and validation, including considerations for clinical trial design, conduct, analysis, interpretation, and reporting for regulatory determinations of medical product benefit.